Santoro A - Search Results

1

Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer.

Parra HS, Cavina R, Latteri F, Zucali PA, Campagnoli E, Morenghi E, Grimaldi GC, Roncalli M, Santoro A. Parra HS, et al. Among authors: santoro a. Br J Cancer. 2004 Jul 19;91(2):208-12. doi: 10.1038/sj.bjc.6601923. Br J Cancer. 2004. PMID: 15187994 Free PMC article.

2

Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma.

Bidoli P, Spinazzè S, Santoro A, Casali P, Bedini AV, Guzzon A. Bidoli P, et al. Among authors: santoro a. Am J Clin Oncol. 1990 Oct;13(5):424-6. doi: 10.1097/00000421-199010000-00012. Am J Clin Oncol. 1990. PMID: 2171319

3

Pilot study with adriamycin and ifosfamide in small cell lung cancer.

Bidoli P, Spinazzé S, Santoro A, Bedini AV, Cataldo I, Bonadonna G. Bidoli P, et al. Among authors: santoro a. Tumori. 1989 Feb 28;75(1):34-7. doi: 10.1177/030089168907500110. Tumori. 1989. PMID: 2540579

4

A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcome.

Santoro A, Parra HS, Bidoli P, Angelidou M, Cataldo I, Salvini P, Valagussa P, Milani F, Ravasi G, Bonadonna G. Santoro A, et al. Semin Oncol. 1995 Feb;22(1 Suppl 2):9-14. Semin Oncol. 1995. PMID: 7846540

5

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.

Viviani S, Camerini E, Bonfante V, Santoro A, Balzarotti M, Fornier M, Devizzi L, Verderio P, Valagussa P, Bonadonna G. Viviani S, et al. Among authors: santoro a. Br J Cancer. 1998 Mar;77(6):992-7. doi: 10.1038/bjc.1998.163. Br J Cancer. 1998. PMID: 9528846 Free PMC article.

6

Dose-escalation of CHOP in non-Hodgkin's lymphoma.

Santoro A, Balzarotti M, Tondini C, Zanini M, Giardini R, Latteri F, Rampinelli I, Bufalino R. Santoro A, et al. Ann Oncol. 1999 May;10(5):519-25. doi: 10.1023/a:1026422224980. Ann Oncol. 1999. PMID: 10416000 Free article.

7

Soft tissue and bone sarcomas.

Santoro A, Parra HS. Santoro A, et al. Cancer Chemother Biol Response Modif. 1999;18:489-97. Cancer Chemother Biol Response Modif. 1999. PMID: 10800499 Review. No abstract available.

8

Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study.

Santoro A, Bredenfeld H, Devizzi L, Tesch H, Bonfante V, Viviani S, Fiedler F, Parra HS, Benoehr C, Pacini M, Bonadonna G, Diehl V. Santoro A, et al. J Clin Oncol. 2000 Jul;18(13):2615-9. doi: 10.1200/JCO.2000.18.13.2615. J Clin Oncol. 2000. PMID: 10893294 Clinical Trial.

9

Treatment perspectives in advanced non-small cell lung cancer.

Soto Parra H, Latteri F, Cavina R, Sala A, Dambrosio M, Alloisio M, Santoro A. Soto Parra H, et al. Among authors: santoro a. Tumori. 2000 Sep-Oct;86(5 Suppl 1):S36-41. Tumori. 2000. PMID: 11195292 Review. No abstract available.

10

Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).

Parra HS, Tixi L, Latteri F, Bretti S, Alloisio M, Gravina A, Lionetto R, Bruzzi P, Dani C, Rosso R, Cosso M, Balzarini L, Santoro A, Ardizzoni A. Parra HS, et al. Among authors: santoro a. Cancer. 2001 Aug 1;92(3):650-6. doi: 10.1002/1097-0142(20010801)92:3<650::aid-cncr1366>3.0.co;2-0. Cancer. 2001. PMID: 11505411 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,009 results

Search Page